Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
13/05/202418:52PR Newswire (US)Alliance College-Ready Public Schools Celebrates over $500,000 in College Scholarships During National Charter Schools Week
13/05/202418:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BROSDutch Bros Inc
13/05/202418:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TMCITreace Medical Concepts Inc
13/05/202418:48Business WireNielsenIQ führt das GenAI-basierte Tool NIQ Ask Arthur in NIQ Discover ein und ermöglicht es den Nutzern so, die Macht der Daten zu erschließen
13/05/202418:48Business WireNielsenIQ lancia lo strumento basato sull’IA generativa NIQ Ask Arthur integrandolo in NIQ Discover e mettendo in grado gli utenti di liberare la potenza dei dati
13/05/202418:48Business WireNielsenIQ lance un outil basé sur l'IA Générative, NIQ Ask Arthur, dans NIQ Discover, permettant aux utilisateurs de tirer parti de la richesse des données
13/05/202418:40PR Newswire (US)ACDi Expands East Coast Presence with Acquisition of Fourth Manufacturing Plant
13/05/202418:37PR Newswire (US)Sweets & Snacks Expo Announces 2024 Most Innovative New Product Awards Winners
13/05/202418:37PR Newswire (US)Develop Fulton Launches International Business Development Efforts, Showcasing South Fulton as Prime Hub for Groundbreaking Growth in the U.S.
13/05/202418:35PR Newswire (Canada)Créer davantage de places dans des services de garde de jeunes enfants pour les familles au Québec
13/05/202418:34GlobeNewswire Inc.Aberdeen International Inc. - Early Warning Press ReleaseTG:A8HAberdeen Intl Inc
13/05/202418:32PR Newswire (US)Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic RetinopathyNASDAQ:KODKodiak Sciences Inc
13/05/202418:31Business WirePACS Group Announces Appointment of Evelyn Dilsaver to Serve as Independent Board DirectorNYSE:PACSPACS Group Inc
13/05/202418:27GlobeNewswire Inc.Dundee Corporation Delivers Success in Its Core Strategy, A Profitable Start to 2024, and Sustained Cost ControlDC-PE
13/05/202418:27PR Newswire (Canada)Sun Life announces third Sustainability Bond OfferingTSX:SLFSun Life Financial Inc
13/05/202418:27PR Newswire (Canada)La Sun Life annonce sa troisième offre d'obligations durablesTSX:SLFSun Life Financial Inc
13/05/202418:24PR Newswire (Canada)Building more child care spaces for families in Quebec
13/05/202418:23PR Newswire (Canada)Avis aux médias - Itinéraire du premier ministre pour le mardi 14 mai 2024
13/05/202418:22Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:HNRAHNR Acquisition Corp
13/05/202418:21Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TTOOT2 Biosystems Inc
13/05/202418:19Business Wireパトロン・キャピタル、日本の投資家が欧州不動産に注目する中、ファンドVIIで1430億円(9億2000万ドル)を超える資金を調達
13/05/202418:15PR Newswire (Canada)GOLD ROYALTY REPORTS FIRST QUARTER 2024 RESULTS; RECORD REVENUE DRIVES POSITIVE OPERATING CASH FLOWAMEX:GROYGold Royalty Corp
13/05/202418:15CointelegraphPepe hits all-time high, memecoins soar after famous GameStop stock trader ‘returns’COIN:PEPEUSDPepe
13/05/202418:12Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:NGSNatural Gas Services Group Inc
13/05/202418:11PR Newswire (Canada)Media Advisory - Prime Minister's itinerary for Tuesday, May 14, 2024
13/05/202418:09Business WireVecima Declares Quarterly DividendTSX:VCMVecima Networks Inc
13/05/202418:09Business WireGRAMINEX®, L.L.C. Publication finale d’un essai clinique à comité de lecture sur l’extrait de pollen de fleur Graminex® axé sur l’incontinence urinaire chez les femmes dans Current Urology.
13/05/202418:06Business WireGRAMINEX®, L.L.C: abschließende Veröffentlichung einer expertengeprüften klinischen Studie zu Graminex® Blütenpollenextrakt bei Harninkontinenz von Frauen in Current Urology
13/05/202418:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PALProficient Auto Logistics Inc
13/05/202418:04Business WireNew Leadership Structure Formed at Sony Interactive Entertainment